EGF mutant receptor vIII as a molecular target in cancer therapy.

in Endocrine-Related Cancer
View More View Less
  • 1 Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA.

 

Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 881 242 13
PDF Downloads 527 177 6